You have 9 free searches left this month | for more free features.

capecitabine

Showing 26 - 50 of 1,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Besançon, France
  • +2 more
Jan 24, 2023

Advanced Colorectal Carcinoma Trial in Beijing (OH2, Capecitabine, Bevacizumab)

Not yet recruiting
  • Advanced Colorectal Carcinoma
  • OH2
  • +2 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jan 28, 2023

Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Apr 6, 2023

HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)

Not yet recruiting
  • HER2-positive Breast Cancer
  • LMD
  • Tucatinib 150 MG
  • +3 more
  • (no location specified)
Aug 24, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022

RECTAL CANCER Trial in Faenza (Capecitabine, Radiotherapy, Durvalumab)

Recruiting
  • RECTAL CANCER
  • Capecitabine
  • +2 more
  • Faenza, Italy
    Ospedale Degli Infermi Uo Oncologia
Jul 19, 2022

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Pseudomyxoma Peritonei Trial in Milano (Capecitabine)

Recruiting
  • Pseudomyxoma Peritonei
  • Capecitabine
  • Milano, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022

Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • Capecitabine
  • +3 more
  • Norfolk, Nebraska
  • +2 more
Aug 10, 2022

Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1

Recruiting
  • Radiotherapy
  • +3 more
  • SBRT radiotherapy + Conventionally fractionated radiotherapy
  • +2 more
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 13, 2022

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)

Not yet recruiting
  • Locally-advanced Rectal Cancer
  • Lyon, Rhöne, France
  • +1 more
Jun 12, 2023

Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2022

Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,

Terminated
  • Rectal Mucinous Adenocarcinoma
  • +8 more
  • Capecitabine
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • dovitinib lactate
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)

Active, not recruiting
  • Elderly Metastatic Colorectal Cancer Patients
  • Capecitabine
  • +2 more
  • Padua, Italy
    Istituto Oncologico Veneto IRCCS
Mar 30, 2022

Breast Cancer, Chemo Effect Trial (Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Capecitabine
  • (no location specified)
Mar 9, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Immunotherapy Trial (Tislelizumab, Capecitabine, oxaliplatin)

Not yet recruiting
  • Immunotherapy
  • (no location specified)
Jul 28, 2022

Glioblastoma Trial in Cleveland (Capecitabine, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 22, 2022

Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))

Completed
  • Pancreatic Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Centers
Feb 10, 2022

Triple-negative Breast Cancer Trial in China (Chiauranib, capecitabine)

Recruiting
  • Triple-negative Breast Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Apr 14, 2022

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Unresectable Pancreatic Neuroendocrine Carcinoma
  • Lutetium Lu 177 Dotatate
  • +4 more
  • (no location specified)
Feb 10, 2022